The Role of Mesenchymal Cells in Cholangiocarcinoma
Author Information
Author(s): Sueca-Comes Mireia, Rusu Elena Cristina, Ashworth Jennifer C., Collier Pamela, Probert Catherine, Ritchie Alison, Meakin Marian, Mongan Nigel P., Egbuniwe Isioma U., Andersen Jesper Bøje, Bates David O., Grabowska Anna M.
Primary Institution: University of Nottingham
Hypothesis
Investigating the role of the tumor microenvironment in cholangiocarcinoma progression could lead to better therapies.
Conclusion
Adding mesenchymal cells to cholangiocarcinoma spheroid models restored key signaling pathways lost in patient-derived xenografts, enhancing tumor growth and viability.
Supporting Evidence
- RNA sequencing indicated upregulation of extracellular matrix-receptor interaction and PI3K-AKT pathways in the presence of mesenchymal cells.
- Histological analysis confirmed biliary phenotypes in the spheroids.
- Viability assays showed that the addition of mesenchymal cells significantly affected the growth of certain cholangiocarcinoma cell lines.
Takeaway
This study shows that adding special cells called mesenchymal cells to cancer models helps the models grow better and act more like real tumors.
Methodology
RNA sequencing was performed on seven cholangiocarcinoma patient-derived xenografts and their corresponding patient samples, followed by differential expression analysis and pathway analysis.
Potential Biases
Potential bias due to the use of mouse models that may not accurately reflect human disease.
Limitations
The study primarily used immunodeficient mice for PDX models, which may not fully replicate the human tumor microenvironment.
Participant Demographics
Patients with cholangiocarcinoma from whom the xenografts were derived.
Statistical Information
P-Value
0.016
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website